Company intelligence / Profile preview

MediTelecare

Connecticut, United Statesmeditelecare.com ↗

Ownership: Private
Employees: ~175
Development stage: Commercial

Overview

MediTelecare has demonstrated significant positive clinical outcomes by reducing inappropriate psychotropic medication use among residents of skilled nursing facilities. Their interdisciplinary team uses evidence-based protocols via telehealth to transition patients from high-risk medications to safer alternatives or non-pharmacologic therapies such as talk therapy. This approach has led to improved quality of care, reduced adverse drug events, and better patient outcomes.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (e.g., talk therapy)Small molecule (psychotropic medications)Device (telehealth technology platform)
Industry: Non-Academic Healthcare

Partnerships

Not explicitly listed; works with over 400 long-term care facilities as community partners.

Beyond the preview

Go deeper on MediTelecare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediTelecare.

Explore the full profile